133 related articles for article (PubMed ID: 31354301)
1. Effects of BCc1 nanoparticle and its mixture with doxorubicin on survival of murine 4T1 tumor model.
Hafizi M; Soleimani M; Noorian S; Kalanaky S; Fakharzadeh S; Tavakolpoor Saleh N; Nazaran MH; Akbari ME
Onco Targets Ther; 2019; 12():4691-4701. PubMed ID: 31354301
[No Abstract] [Full Text] [Related]
2. BCc1, the novel antineoplastic nanocomplex, showed potent anticancer effects in vitro and in vivo.
Kalanaky S; Hafizi M; Fakharzadeh S; Vasei M; Langroudi L; Janzamin E; Hashemi SM; Khayamzadeh M; Soleimani M; Akbari ME; Nazaran MH
Drug Des Devel Ther; 2016; 10():59-70. PubMed ID: 26766901
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients.
Hafizi M; Kalanaky S; Moaiery H; Khayamzadeh M; Noorian S; Kaveh V; Gharib B; Foudazi H; Razavi M; Jenabian A; Salimi S; Sereshki MMA; Mirzaei HR; Zarghi A; Fakharzadeh S; Nazaran MH; Akbari ME
J Nanobiotechnology; 2019 Apr; 17(1):52. PubMed ID: 30971278
[TBL] [Abstract][Full Text] [Related]
4. BCc1 Nanomedicine Therapeutic Effects in Streptozotocin and High-Fat Diet Induced Diabetic Kidney Disease.
Fakharzadeh S; Argani H; Dadashzadeh S; Kalanaky S; Mohammadi Torbati P; Nazaran MH; Basiri A
Diabetes Metab Syndr Obes; 2020; 13():1179-1188. PubMed ID: 32368111
[TBL] [Abstract][Full Text] [Related]
5. [The therapeutic effect of HSV1-hGM-CSF combined with doxorubicin on the mouse breast cancer model].
Zhuang XF; Zhang SR; Liu BL; Wu JL; Li XQ; Gu HG; Shu Y
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):178-185. PubMed ID: 29575835
[No Abstract] [Full Text] [Related]
6.
Akbaribazm M; Khazaei MR; Khazaei M
Food Sci Nutr; 2020 Aug; 8(8):4276-4290. PubMed ID: 32884708
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Immunohistochemical Findings and Clinical Features Associated with Local Aggressiveness in Basal Cell Carcinoma.
ShamsiMeymandi S; Dabiri S; ZeynadiniMeymand A; Iranpour M; Khalili M; Alijani S; Aflatoonian M
Iran J Pathol; 2019; 14(3):193-196. PubMed ID: 31582995
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the therapeutic efficacy of 188Rhenium-liposomes and liposomal doxorubicin in a 4T1 murine orthotopic breast cancer model.
Liu CM; Lee WC; Yu CY; Lan KL; Chang CH; Ting G; Lee TW
Oncol Rep; 2012 Mar; 27(3):678-84. PubMed ID: 22109644
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin Changes Bax /Bcl-xL Ratio, Caspase-8 and 9 in Breast Cancer Cells.
Sharifi S; Barar J; Hejazi MS; Samadi N
Adv Pharm Bull; 2015 Sep; 5(3):351-9. PubMed ID: 26504757
[TBL] [Abstract][Full Text] [Related]
10. Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity.
Zhao S; Yu Q; Pan J; Zhou Y; Cao C; Ouyang JM; Liu J
Acta Biomater; 2017 May; 54():294-306. PubMed ID: 28267598
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro.
Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q
Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772
[TBL] [Abstract][Full Text] [Related]
12. Enhanced chemotherapeutic efficacy of the low-dose doxorubicin in breast cancer via nanoparticle delivery system crosslinked hyaluronic acid.
Wang Q; Zhong Y; Liu W; Wang Z; Gu L; Li X; Zheng J; Du H; Zhong Z; Xie F
Drug Deliv; 2019 Dec; 26(1):12-22. PubMed ID: 30691317
[TBL] [Abstract][Full Text] [Related]
13. In vivo anticancer synergy mechanism of doxorubicin and verapamil combination treatment is impaired in BALB/c mice with metastatic breast cancer.
McCarthy M; Auda G; Agrawal S; Taylor A; Backstrom Z; Mondal D; Moroz K; Dash S
Exp Mol Pathol; 2014 Aug; 97(1):6-15. PubMed ID: 24780744
[TBL] [Abstract][Full Text] [Related]
14. Amelioration effect of Egyptian sweet orange hesperidin on Ehrlich ascites carcinoma (EAC) bearing mice.
Donia TIK; Gerges MN; Mohamed TM
Chem Biol Interact; 2018 Apr; 285():76-84. PubMed ID: 29481770
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable and amphiphilic block copolymer-doxorubicin conjugate as polymeric nanoscale drug delivery vehicle for breast cancer therapy.
Yang Y; Pan D; Luo K; Li L; Gu Z
Biomaterials; 2013 Nov; 34(33):8430-43. PubMed ID: 23896006
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin-conjugated polypeptide nanoparticles inhibit metastasis in two murine models of carcinoma.
Mastria EM; Chen M; McDaniel JR; Li X; Hyun J; Dewhirst MW; Chilkoti A
J Control Release; 2015 Jun; 208():52-8. PubMed ID: 25637704
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: A mechanistic insight.
Rai G; Mishra S; Suman S; Shukla Y
Phytomedicine; 2016 Mar; 23(3):233-42. PubMed ID: 26969377
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the ER Ca2+ channel BCC1 from tendrils of Bryonia dioica by divalent cations, protons and H2O2.
Klüsener B; Boheim G; Weiler EW
FEBS Lett; 1997 Apr; 407(2):230-4. PubMed ID: 9166905
[TBL] [Abstract][Full Text] [Related]
19. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
[TBL] [Abstract][Full Text] [Related]
20. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
Wong HL; Rauth AM; Bendayan R; Wu XY
Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
